XML 51 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating expenses        
Research and development $ 1,684,215 $ 1,421,851 $ 5,747,399 $ 3,360,563
General and administrative 1,613,983 1,888,119 8,901,197 5,966,504
Total operating expenses 3,298,198 3,309,970 14,648,596 9,327,067
Operating loss (3,298,198) (3,309,970) (14,648,596) (9,327,067)
Other income 12,284 104 26,846 242
Loss before income taxes (3,285,914) (3,309,866) (14,621,750) (9,326,825)
Income taxes
Net loss (3,285,914) (3,309,866) (14,621,750) (9,326,825)
Deemed dividend attributable to preferred stock (11,479,308)
Net loss applicable to common shareholders $ (3,285,914) $ (3,309,866) $ (14,621,750) $ (20,806,133)
Loss per common share - basic and diluted (in dollars per share) $ (0.36) $ (0.64) $ (1.77) $ (5.71)
Weighted average shares outstanding - basic and diluted (in shares) 9,130,057 5,183,492 8,283,302 3,645,682